Clinical Trials on Breast Mass in South Africa
Total 853 results
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
Virginia Commonwealth UniversityCompletedLymphoma | Breast Cancer | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Canadian Cancer Trials Group; Southwest Oncology... and other collaboratorsCompletedHER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Peru, South Africa
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Pure Biologics S.A.Presage BiosciencesRecruitingTriple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Soft Tissue Sarcoma AdultUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Joint PainUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
Barwon HealthAstraZenecaCompletedBreast CancerAustralia
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerSaudi Arabia, Argentina, Belgium, Spain, Italy, Korea, Republic of, South Africa, France, Netherlands
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, South Africa, Brazil
-
AbbottCompletedBreast CancerUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; Celgene CorporationCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Provista Diagnostics, IncUnknownBreast CancerUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedDepression | Breast Cancer | Weight ChangesUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); United States Department of Defense and other collaboratorsRecruitingBreast Cancer | Breast Cancer Screening | Breast Carcinoma in SituUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedCancer | Fatigue | Breast CarcinomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast CancerUnited States, South Africa, Canada, Argentina, Chile, Bulgaria, Croatia, Netherlands, Estonia, Denmark, Poland, Brazil, Mexico, Romania
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedBreast Cancer | Breast NeoplasmsUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Avelas Biosciences, Inc.Clinipace Worldwide; RRD International, Inc.CompletedStage I Breast Cancer | Stage II Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female | Stage III Breast Cancer | Carcinoma Breast | Primary Invasive Malignant Neoplasm of Female BreastUnited States
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteActive, not recruiting
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more
-
SCRI Development Innovations, LLCNovartisCompletedMetastatic Breast CancerUnited States
-
MedImmune LLCWithdrawnBreast CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAtypical Hyperplasia of the Breast | Lobular Breast Carcinoma In Situ | Pleomorphic Lobular Breast Carcinoma In SituUnited States, Guam
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Eli Lilly and CompanyCompleted
-
University of NottinghamAstraZeneca; Cancer Research UK; National Cancer Research NetworkCompleted
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupActive, not recruitingBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Sweden, Hungary, India, Germany, Brazil
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); American College of Radiology Imaging NetworkActive, not recruitingStage II Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerSweden, Canada, South Africa, Spain, United Kingdom, Germany, Taiwan, Switzerland, New Zealand, Italy, Bosnia and Herzegovina, Serbia, Portugal, Greece, Romania, Brazil, Korea, Republic of, Mexico, Croatia, Bahamas
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium